Biotech Company Receives Major Rating From This Stock Analyst
TransCode Therapeutics Maintains $3 Price Target: A Detailed Analysis by HC Wainwright & Co.
Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.
Why is this Relevant to You?
TransCode Therapeutics, a clinical-stage biotech company, is making significant strides in the development of targeted therapeutics for drug…